Table 2. Baseline characteristics of in-hospital survivors and non-survivors.
| Non-survivors (N=332) | Survivors (N=303) | P | |
|---|---|---|---|
| Age (years) | 52 (18–80) | 50 (17–88) | 0.046 |
| Gender (%) | |||
| Male | 198 (59.8) | 197 (65.2) | 0.186 |
| Female | 133 (40.2) | 105 (34.8) | |
| Liver disease (%) | |||
| Alcoholic liver disease | 207 (62.5) | 195 (64.4) | |
| Autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cirrhosis, Wilson's disease | 27 (8.2) | 19 (6.3) | |
| Chronic hepatitis C | 39 (11.8) | 19 (6.3) | 0.04 |
| Chronic hepatitis B | 25 (7.6) | 20 (6.6) | |
| Cryptogenic cirrhosis | 9 (2.7) | 12 (4) | |
| Alcoholic liver disease and viral hepatitis | 10 (2.5) | 10 (3.3) | |
| Other | 14 (4.2) | 28 (9.2) | |
| Indication for ICU admission (%) | |||
| Respiratory failure | 14 (4.2) | 9 (3) | |
| Sepsis | 102 (30.7) | 50 (16.6) | |
| Renal failure | 49 (14.8) | 12 (4) | <0.0005 |
| Multiorgan failure | 33 (9.9) | 5 (1.7) | |
| Variceal bleeding | 82 (24.7) | 170 (56.3) | |
| Encephalopathy | 25 (7.5) | 20 (6.6) | |
| Other | 27 (8.1) | 36 (11.9) | |
| Length of ICU stay (days)a | 5 (0–42) | 5 (0–71) | 0.408 |
ICU, intensive care unit.
a
Median (range).